• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Jerry Younger, MD

Publications

  • Lin NU, Freedman RA, Ramakrishna N, Younger J, Storniolo AM, Bellon JR, Come SE, Gelman RS, Harris GJ, Henderson MA, Macdonald SM, Mahadevan A, Eisenberg E, Ligibel JA, Mayer EL, Moy B, Eichler AF, Winer EP.A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases.Breast Cancer Res Treat. 2013 Nov;142(2):405-14.
    24197661
  • Boutrus RR, Abi Raad RF, Kuter I, Ancukiewicz M, Roberts L, Solomon N, Ngo T, Borick H, Ryan P, Moy B, Gadd M, Chien J, Younger J, Smith B, Taghian AG, Harris L.Circulating tumor cells as predictors of response and failure in breast cancer patients treated with preoperative chemotherapy.Int J Biol Markers. 2012 Sep 17:0.
    23015398
  • Michaelson JS, Chen LL, Bush D, Fong A, Smith B, Younger J.Improved web-based calculators for predicting breast carcinoma outcomes.Breast Cancer Res Treat. 2011 Feb 15.
    21327471
  • Bush D, Smith B, Younger J, Michaelson JS.The non-breast-cancer death rate among breast cancer patients.Breast Cancer Res Treat. 2010 Oct 7.
    20927583
  • Michaelson JS, Chen LL, Silverstein MJ, Mihm MC, Sober AJ, Tanabe KK, Smith BL, Younger J.How cancer at the primary site and in the lymph nodes contributes to the risk of cancer death.Cancer. 2009 Nov 1;115(21):5095-107.
    19670458
  • Michaelson JS, Chen LL, Silverstein MJ, Cheongsiatmoy JA, Mihm MC, Sober AJ, Tanabe KK, Smith BL, Younger J.Why cancer at the primary site and in the lymph nodes contributes to the risk of cancer death.Cancer. 2009 Nov 1;115(21):5084-94.
    19670457
  • Chen LL, Nolan ME, Silverstein MJ, Mihm MC, Sober AJ, Tanabe KK, Smith BL, Younger J, Michaelson JS.The impact of primary tumor size, lymph node status, and other prognostic factors on the risk of cancer death.Cancer. 2009 Nov 1;115(21):5071-83.
    19658184
  • Hesketh PJ,Younger J,Sanz-Altamira P,Hayden M,Bushey J,Trainor B,Krentzin M,Nowd P,Arnaoutakis K,Hesketh AM.Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide.Support Care Cancer. 2008 Dec 6.
    19066985
  • Burstein HJ,Chen YH,Parker LM,Savoie J,Younger J,Kuter I,Ryan PD,Garber JE,Chen H,Campos SM,Shulman LN,Harris LN,Gelman R,Winer EP.VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy.Clin Cancer Res. 2008 Dec 1;14(23):7871-7.
    19047116
  • Eichler AF, Kuter I, Ryan P, Schapira L, Younger J, Henson JW.Survival in patients with brain metastases from breast cancer: the importance of HER-2 status.Cancer. 2008 Jun;112(11):2359-67.
    18361426
  • Lin NU, Carey LA, Liu MC, Younger J, Come SE, Ewend M, Harris GJ, Bullitt E, Van den Abbeele AD, Henson JW, Li X, Gelman R, Burstein HJ, Kasparian E, Kirsch DG, Crawford A, Hochberg F, Winer EP.Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.J Clin Oncol. 2008 Apr 20;26(12):1993-9.
    18421051
  • Liu MC, Demetri GD, Berry DA, Norton L, Broadwater G, Robert NJ, Duggan D, Hayes DF, Henderson IC, Lyss A, Hopkins J, Kaufman PA, Marcom PK, Younger J, Lin N, Tkaczuk K, Winer EP, Hudis CA.Dose-escalation of filgrastim does not improve efficacy: Clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel.Cancer Treat Rev. 2008 May;34(3):223-230.
    18234424
  • Younger JF, Plein S, Barth J, Ridgway JP, Ball SG, Greenwood JP.Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction.Heart. 2007 Dec;93(12):1547-51.
    17540686
  • Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E.Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.Psychooncology. 2007 Oct;16(10):895-903.
    17245695
  • Burstein HJ, Overmoyer B, Gelman R, Silverman P, Savoie J, Clarke K, Dumadag L, Younger J, Ivy P, Winer EP.Rebeccamycin analog for refractory breast cancer: a randomized phase II trial of dosing schedules.Invest New Drugs. 2007 Apr;25(2):161-4.
    16969707
  • Burstein HJ, Parker LM, Keshaviah A, Doherty J, Partridge AH, Schapira L, Ryan PD, Younger J, Harris LN, Moy B, Come SE, Schumer ST, Bunnell CA, Haldoupis M, Gelman R, Winer EP.Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy.J Clin Oncol. 2005 Nov 20;23(33):8340-7.
    16293865
  • Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A, Muir B, Mohapatra G, Salunga R, Tuggle JT, Tran Y, Tran D, Tassin A, Amon P, Wang W, Wang W, Enright E, Stecker K, Estepa-Sabal E, Smith B, Younger J, Balis U, Michaelson J, Bhan A, Habin K, Baer TM, Brugge J, Haber DA, Erlander MG, Sgroi DC.A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.Cancer Cell. 2004 Jun;5(6):607-16.
    15193263
  • Bendell JC, Domchek SM, Burstein HJ, Harris L, Younger J, Kuter I, Bunnell C, Rue M, Gelman R, Winer E.Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.Cancer. 2003 Jun 15;97(12):2972-7.
    12784331
  • Burstein HJ, Harris LN, Gelman R, Lester SC, Nunes RA, Kaelin CM, Parker LM, Ellisen LW, Kuter I, Gadd MA, Christian RL, Kennedy PR, Borges VF, Bunnell CA, Younger J, Smith BL, Winer EP.Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study.J Clin Oncol. 2003 Jan 1;21(1):46-53.
    12506169
  • Taghian AG, Assaad SI, Niemierko A, Kuter I, Younger J, Schoenthaler R, Roche M, Powell SN.Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel.J Natl Cancer Inst. 2001 Dec 5;93(23):1806-11.
    11734597
  • Burstein HJ, Kuter I, Campos SM, Gelman RS, Tribou L, Parker LM, Manola J, Younger J, Matulonis U, Bunnell CA, Partridge AH, Richardson PG, Clarke K, Shulman LN, Winer EP.Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer.J Clin Oncol. 2001 May 15;19(10):2722-30.
    11352965
  • Duffy LS, Greenberg DB, Younger J, Ferraro MG.Iatrogenic acute estrogen deficiency and psychiatric syndromes in breast cancer patients.Psychosomatics. 1999 Jul-Aug;40(4):304-8.
    10402875
  • FitzGerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, Silva-Arrieto S, Finkelstein DM, Beer-Romero P, Englert C, Sgroi DC, Smith BL, Younger JW, Garber JE, Duda RB, Mayzel KA, Isselbacher KJ, Friend SH, Haber DA.Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.N Engl J Med. 1996 Jan 18;334(3):143-9.
    8531968
  • Wood WC, Budman DR, Korzun AH, Cooper MR, Younger J, Hart RD, Moore A, Ellerton JA, Norton L, Ferree CR.Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma.N Engl J Med. 1994 May 5;330(18):1253-9.
    8080512